The upregulation of NRF2-mediated cytoprotective and phase II detoxifying enzymes, without direct evidence of KPT-6566’s effects on NRF2 protein/mRNA levels and its interaction with PIN1, raises questions about its impact on cellular resistance and promotion of a tumour-supportive environment. Here, NFE2L2 is linked to neoplasm.